– DualCap System™ Core Technology Protected by 17 Patents –
SALT LAKE CITY – October 1, 2015 – Catheter Connections, Inc. (CCI) today announced the
issuance of three additional patents from the United States Patent and Trademark Office covering its
proprietary DualCap System™. DualCap® helps prevent catheter-related bloodstream infections
(CRBSIs), including central line-associated blood stream infections (CLABSIs), to improve patient
safety during intravenous (IV) therapy.
The three newly issued patents add to the core patented technology that comprises the company’s
– Former Durata Therapeutics and Baxter International Executive Tapped to Build
Commercial Capabilities, Expand Market Adoption of DualCap System™ –
SALT LAKE CITY – July 23, 2015 – Catheter Connections, Inc. (CCI) today announced the hiring of
John P. Shannon as the company’s chief executive officer and member of the board of directors.
Former CCI CEO Jeffery L. McCoy will continue with the company as chairman of the board of
CCI develops and commercializes innovative vascular access products designed to protect patients
from acquiring infections during…
ST. PAUL, Minn. and SALT LAKE CITY – June 15, 2015 – 3M and Catheter Connections, Inc. announced today that they have settled the patent infringement litigation in the United States District Courts of California and Utah and at the United States Patent and Trademark Office between 3M’s newly acquired Ivera Medical Corp. and Catheter Connections Inc. The settlement relates to disinfecting port protector intellectual property, including Catheter Connections’ DualCap System™ products and 3M™ Curos™ products and resolves all disputes between the two parties. The specific terms of…
Catheter Connections, developer of DualCap™ disinfectant caps, is proud to announce that we have updated our Instructions For Use (IFU) and enhanced the indications for use for our DualCap™ disinfectant caps to be effective for disinfecting both the needleless access ports as well as the male luer connectors. The new indication for use is: When left in place for 30 seconds, the disinfecting caps disinfect the luer access valve and the male luer connector and provide a physical barrier to contamination for up to 7 days under normal conditions if not removed. This is a change from our…
Innovative Technology Saves Lives and Key to Reducing Infections and Improving Overall Patient Care
Catheter Connections, originator of the DualCap System™, is proud to have been awarded a GPO contract by MedAssets. The DualCap System will provide MedAssets’ 4400+ healthcare facilities across the nation easy access to DualCap, giving them a tool to save lives and greatly reduce hospital-acquired conditions, particularly catheter related bloodstream infections (CRBSI)
DualCap is the first FDA cleared and patented disinfection cap that safely disinfects and protects male luer connectors…
Designed by infusion nurses, the DualCap System™ safely disinfects both IV tubing end connectors and needle-free valves, providing healthcare facilities with a cost-effective, integrated solution for IV disinfection and protection, and helping in the fight against IV catheter-related blood stream infections.